Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cingulate Inc (CING)
NASDAQ:CING
Holding CING?
Track your performance easily
CING Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.80 - $89.70
Previous CloseN/A
Volume136.88K
Average Volume (3M)151.99K
Market Cap
$13.84M
Enterprise Value-$903.51K
Total Cash (Recent Filing)$437.19K
Total Debt (Recent Filing)$1.71M
Price to Earnings (P/E)―
Beta5.18
Next Earnings
Mar 07, 2025EPS Estimate
-1.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-85.79
Shares Outstanding3,212,233
10 Day Avg. Volume296,523
30 Day Avg. Volume151,989
Standard Deviation0.35
R-Squared0.02
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.07
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.09
Forecast
1Y Price Target
$8.00Price Target Upside85.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cingulate Inc News
PremiumCompany Announcements
Cingulate Inc Completes Key FDA Study for ADHD Drug
PremiumCompany Announcements
Cingulate Inc Secures $5M Financing for Strategic Growth
Options Prices
Currently, No data available
---
Ownership Overview
63.15% Insiders
0.09% Mutual Funds
<0.01% Other Institutional Investors
36.73% Public Companies and Individual Investors
CING FAQ
What was Cingulate Inc’s price range in the past 12 months?
Cingulate Inc lowest stock price was $1.80 and its highest was $89.70 in the past 12 months.
What is Cingulate Inc’s market cap?
Cingulate Inc’s market cap is $13.84M.
When is Cingulate Inc’s upcoming earnings report date?
Cingulate Inc’s upcoming earnings report date is Mar 07, 2025 which is in 57 days.
How were Cingulate Inc’s earnings last quarter?
Cingulate Inc released its earnings results on Nov 07, 2024. The company reported -$1.83 earnings per share for the quarter, beating the consensus estimate of -$2.363 by $0.533.
Is Cingulate Inc overvalued?
According to Wall Street analysts Cingulate Inc’s price is currently Undervalued.
Does Cingulate Inc pay dividends?
Cingulate Inc does not currently pay dividends.
What is Cingulate Inc’s EPS estimate?
Cingulate Inc’s EPS estimate is -1.21.
How many shares outstanding does Cingulate Inc have?
Cingulate Inc has 3,212,233 shares outstanding.
What happened to Cingulate Inc’s price movement after its last earnings report?
Cingulate Inc reported an EPS of -$1.83 in its last earnings report, beating expectations of -$2.363. Following the earnings report the stock price went up 2.381%.
Which hedge fund is a major shareholder of Cingulate Inc?
Among the largest hedge funds holding Cingulate Inc’s share is GoalVest Advisory LLC. It holds Cingulate Inc’s shares valued at 0.
---
Company Description
Cingulate Inc
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
---
CING Stock 12 Month Forecast
Average Price Target
$8.00
▲(85.61% Upside)
Technical Analysis
Relmada Therapeutics
―
Axsome Therapeutics
―
Medicinova
―
SELLAS Life Sciences Group
―
Blueprint Medicines
―
Evolus
―
Best Analysts Covering CING
1 Year
1 Year Success Rate
1/9 ratings generated profit
1 Year Average Return
-61.53%
reiterated a buy rating 2 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 11.11% of your transactions generating a profit, with an average return of -61.53% per trade.
---